BD 2141915 - PowerLoc MAX PAK Safety Infusion Set, 19G x 1.5", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2141915 - PowerLoc MAX PAK Safety Infusion Set, 19G x 1.5", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2141915 PowerLoc MAX PAK Safety Infusion Set is a sterile port-access solution designed for accessing compatible implanted vascular access ports for infusion therapy, blood withdrawal, flushing, and power-injection procedures when clinically indicated. The set features a 19-gauge non-coring needle with a 1.5-inch length and is configured without a Y-injection site.

The PowerLoc MAX design combines power-injection capability with an integrated safety mechanism intended to help reduce accidental needlestick exposure during needle removal, transportation, and disposal. As the needle is withdrawn through the base, the safety mechanism covers the needle bevel and locks it within the protective housing.

A low-profile, stable needle base supports site management and dressing placement, while the padded footprint is designed to promote patient comfort during access. The clear base helps clinicians observe the insertion area, and the rotating needle hub supports tubing positioning and site dressing.

The MAX PAK configuration provides an organized port-access solution intended to simplify the multi-step sterile preparation process. BD 2141915 is supplied without a Y-injection site and packaged five sets per case.

Key Benefits

• 19-gauge non-coring needle supports access to compatible implanted vascular ports.
• 1.5-inch needle length accommodates port placement situations requiring a longer access needle.
• Power-injectable design supports compatible contrast-enhanced imaging procedures when used according to manufacturer instructions.
• Integrated safety mechanism covers and locks the needle bevel after removal.
• Single-step safety activation helps reduce the risk of accidental needlestick injuries.
• Low-profile base supports secure dressing placement and ongoing site care.
• Padded, non-absorbent footprint is designed to support patient comfort.
• Rotating needle hub allows clinicians to position the tubing for convenient site management.
• Clear base supports visual inspection of the access site.
• Wingless design can simplify dressing application around the port-access device.
• Compatible with appropriate dual-lumen implanted ports.
• Configuration without a Y-injection site provides a direct fluid pathway for workflows that do not require secondary access.
• MAX PAK format helps organize the components required for an established port-access procedure.
• Convenient five-per-case packaging supports clinical inventory management.

Compatibility and Applications

The BD 2141915 PowerLoc MAX PAK Safety Infusion Set is designed for use with compatible implanted vascular access ports that accept non-coring port-access needles. It is particularly suited for compatible power-injectable ports when contrast media or another approved fluid must be delivered using a power injector.

Potential clinical applications include intravenous medication administration, hydration therapy, chemotherapy, long-term infusion therapy, parenteral nutrition, blood product administration, blood specimen withdrawal, port flushing, and contrast-enhanced diagnostic imaging. The specific application must be consistent with the implanted port, prescribed therapy, device labeling, and institutional policy.

The 19-gauge configuration may be selected when the required therapy, flow characteristics, implanted port specifications, and clinician judgment support the use of a larger-gauge port-access needle. The 1.5-inch length is intended for port placements where a longer needle is necessary to reach and access the port septum securely.

The set is configured without a Y-injection site. It may be appropriate for procedures that use a direct connection and do not require a secondary injection or medication-access point within the tubing.

Compatibility should be confirmed with the exact implanted port model, port depth, septum design, prescribed therapy, connector system, infusion pump, power injector, dressing, and institutional vascular-access protocol before use.

Usage Guidelines

The BD 2141915 should be used only by healthcare professionals who are trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional policy, and the implanted port manufacturer's instructions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status.
• Verify that the 19-gauge, 1.5-inch needle is appropriate for the patient's port depth and intended procedure.
• Inspect the package for damage, moisture, punctures, contamination, or evidence of compromised sterility.
• Prepare the port-access site using the antiseptic technique required by institutional policy.
• Prime the infusion set completely using aseptic technique and an approved solution.
• Stabilize the implanted port and insert the non-coring needle perpendicular to the septum using the approved access technique.
• Advance the needle only until appropriate contact with the base of the port reservoir is achieved.
• Verify correct needle placement according to facility policy, including aspiration for blood return when clinically appropriate.
• Flush the port according to the implanted port manufacturer's instructions and institutional protocol.
• Secure and dress the access site using an approved sterile dressing system.
• Inspect the site routinely for pain, swelling, leakage, redness, displacement, or other complications.
• Confirm power-injection eligibility before connecting the set to a power injector.
• Do not exceed the pressure, flow-rate, or contrast-media specifications established for the complete access system.
• After therapy, flush and lock the port according to the prescribed protocol.
• Activate the integrated safety mechanism during removal and confirm that the needle is fully covered and locked.
• Dispose of the used set immediately in an approved sharps container.

Resistance during flushing or infusion, inability to obtain expected blood return, patient discomfort, swelling, leakage, or changes at the access site may indicate improper placement or another complication. Stop the procedure and assess the device according to institutional policy.

Certifications and Safety Standards

The BD 2141915 PowerLoc MAX PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, infection-prevention, and occupational safety programs.

The integrated safety mechanism is designed to cover and secure the needle bevel following removal. This feature supports exposure-control practices intended to reduce needlestick injuries and occupational exposure to bloodborne pathogens. It does not replace proper access technique, sharps handling, personal protective equipment, or immediate disposal in an approved sharps container.

The set should be incorporated into facility procedures covering implanted port assessment, aseptic access, securement, dressing management, infusion administration, power injection, deaccessing, sharps disposal, and management of suspected complications.

Healthcare organizations should review current manufacturer documentation for applicable FDA clearance, UDI information, sterilization method, shelf life, material composition, natural rubber latex status, DEHP information, maximum pressure, maximum flow rate, and other regulatory or technical requirements.

Comparison with Competitors

Compared with conventional non-safety port-access needles, the BD PowerLoc MAX incorporates a protective mechanism that covers and locks the needle bevel during removal. This design can support safer handling between port deaccessing and final sharps disposal.

Compared with winged port-access needles, the wingless and low-profile PowerLoc MAX base can provide a smaller dressing profile and improved visibility around the access site. Selection between winged and wingless designs depends on clinician preference, securement technique, and facility protocol.

Compared with non-power-injectable port-access sets, the PowerLoc MAX is designed for power injection when connected to a compatible power-injectable implanted port and used within the specified operating limits. Non-power-rated needles should not be substituted for procedures requiring powered delivery of contrast media.

Compared with sets that include a Y-injection site, BD 2141915 provides a direct configuration without a secondary access point. This may simplify the fluid pathway when secondary administration is unnecessary, although a Y-site model may be preferred when additional access is required.

Compared with shorter needle options, the 1.5-inch needle can accommodate deeper implanted ports or patients with greater tissue depth over the port. Needle length must be selected carefully because a needle that is too short may not access the septum correctly, while an unnecessarily long needle may affect stability or dressing placement.

Alternative products may differ in gauge, needle length, base size, padding, safety activation, power-injection capability, tubing design, Y-site configuration, included accessories, and packaging. The BD 2141915 combines a 19-gauge, 1.5-inch non-coring needle with power-injection capability, an integrated safety mechanism, and a low-profile padded base.

Typical User Profile and Application Scenarios

The BD 2141915 PowerLoc MAX PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified personnel.

Common application environments include hospitals, outpatient infusion centers, oncology clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other facilities where implanted ports are routinely accessed.

The product may be selected for patients whose implanted port depth requires a 1.5-inch needle and whose prescribed therapy or diagnostic procedure is compatible with a 19-gauge access device.

Typical scenarios include accessing an implanted port for chemotherapy, administering long-duration infusion therapy, obtaining blood specimens, maintaining port patency, and delivering contrast media during compatible computed tomography imaging procedures.

The configuration without a Y-injection site is particularly relevant for facilities that prefer a direct tubing pathway or do not require secondary medication administration through the access set.

Best Practices for Use and Maintenance

The BD 2141915 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on correct product selection, storage, aseptic preparation, access technique, site monitoring, safety activation, and disposal.

• Store unopened sets under the temperature and environmental conditions specified by the manufacturer.
• Protect packages from moisture, excessive heat, freezing, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the catalog number, gauge, needle length, and Y-site configuration before opening the package.
• Assess the depth and position of the implanted port before choosing the 1.5-inch needle.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the tubing fully to remove air before connecting it to the implanted port.
• Use an appropriate stabilization method to reduce port movement during access.
• Position the rotating hub and tubing to reduce pulling, pressure, and dressing disruption.
• Inspect the access site regularly throughout therapy.
• Verify the power-injectable status of every component before a powered procedure.
• Never exceed the lowest pressure or flow limitation of any component within the system.
• Do not bend, cut, modify, repair, or otherwise alter the infusion set.
• Do not reuse, clean, resterilize, or reprocess the single-use device.
• Confirm complete safety activation immediately after needle withdrawal.
• Place the protected needle directly into an approved sharps container after removal.

Regulatory and Safety Information

The BD 2141915 PowerLoc MAX PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, the implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 19-gauge size, 1.5-inch needle length, sterile package integrity, expiration date, and compatibility with the implanted port. Do not use a set that is expired, damaged, contaminated, or supplied in compromised packaging.

The device should not be used for power injection unless the implanted port and every connected component are specifically identified as power injectable. Clinicians must verify the permitted flow rate, pressure limit, contrast-media viscosity, and operating conditions before beginning the procedure.

Incorrect needle length, incomplete septum access, needle displacement, excessive pressure, or improper securement may cause infiltration, extravasation, tissue injury, port damage, leakage, interrupted therapy, or other complications.

The absence of a Y-injection site means that secondary access is not available through this set configuration. Clinical teams should confirm that this configuration is suitable for the intended therapy before opening the package.

The integrated safety mechanism must be activated according to the manufacturer's instructions. Used port-access needles remain contaminated sharps even after safety activation and must be disposed of immediately in an approved sharps container.

The CIA Medical listing identifies this item as temperature sensitive, non-returnable, available only within the continental United States, and supplied as a special-order product. Buyers should confirm the catalog number, quantity, shipping eligibility, storage conditions, and current product availability before ordering.

How to Order

Select the BD 2141915 - PowerLoc MAX PAK Safety Infusion Set without Y-Injection Site, 19G x 1.5" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.